| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 07/28/2004 | EP1226244B1 Polypeptides with non-natural primary signalling motifs |
| 07/28/2004 | EP1189517B1 Method for the production of an immunostimulant milk product and uses thereof |
| 07/28/2004 | EP1186654B1 Bacteria strain lactobacillus acidophilus n.v. ep 317/402 narine aaa used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof |
| 07/28/2004 | EP1121331B1 Microbiological method for eliminating a nitroaromatic compound |
| 07/28/2004 | EP1011331B1 Inhibition of sulfate-reducing-bacteria-mediated degradation using bacteria which secrete antimicrobials |
| 07/28/2004 | EP0977869B1 Lipase and use of same for improving doughs and baked products |
| 07/28/2004 | EP0938501B1 Process for the purification of human interleukin-1 receptor antagonist from recombinant e. coli |
| 07/28/2004 | EP0912741B1 T-cell selective interleukin-4 agonists |
| 07/28/2004 | EP0584214B1 Gene manipulation and expression using genomic elements |
| 07/28/2004 | EP0452484B2 Production of proteins using homologous recombination |
| 07/28/2004 | CN1516738A Acetylation of GP41 framgnets |
| 07/28/2004 | CN1516735A Method to generate non-virulent microorganism from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production |
| 07/28/2004 | CN1516706A Endogenous and non-endogenous versions of human G protein-coupled receptors |
| 07/28/2004 | CN1515676A Production of chitosan and chitin |
| 07/28/2004 | CN1515674A Biological pure culture for Nocardia |
| 07/28/2004 | CN1515672A Human chemotactic factor beta-8, chemotactic factor beta-1 and macrophage inflammatory protein-4 |
| 07/28/2004 | CN1515670A Method for producing highly basic alkali protease |
| 07/28/2004 | CN1515668A Preparation process of enzyme preparation |
| 07/28/2004 | CN1515667A Livstock mucosal competitive exclusion culture for reducing enteropathogenic bacteria |
| 07/28/2004 | CN1515666A Method for screening pseudomonads for controlling blight |
| 07/28/2004 | CN1515648A Method for treating and controlling desertificated land |
| 07/28/2004 | CN1515591A Growth hormone and serum albumni recombinant fusion protein |
| 07/28/2004 | CN1159584C Method and medicine box of testing anti-hepatitis C virus antibody |
| 07/28/2004 | CN1159450C Low oxygen affinity mutant hemoglobin |
| 07/28/2004 | CN1159444C Mutated penicilling acylase genes |
| 07/28/2004 | CN1159443C Method for producing L-lysine |
| 07/28/2004 | CN1159442C Novel stranis of bacillus subtilis group for food fermentation |
| 07/28/2004 | CN1159436C Ensyme with aminopeptidase activity |
| 07/28/2004 | CN1159435C Sludge magnetotatic bacterium and process for separating and puifying it and preparing magnetic corpuscula |
| 07/28/2004 | CN1159434C Pseudomonas stutzeri Zh9944 and microbial prepn for bacterial wilt preventing and controlling |
| 07/28/2004 | CN1159432C Separated strain of Antrodia camphorate, process for preparing its culture medium and its product |
| 07/28/2004 | CN1159341C Method of treatment of corticosteroid induced osteopenia |
| 07/27/2004 | US6768001 Xylanase from trichoderma reesei, method for production thereof, and methods employing this enzyme |
| 07/27/2004 | US6767894 Use of ciliary neurotrophic factor |
| 07/27/2004 | US6767879 Detergents comprising cellulases |
| 07/27/2004 | US6767744 Isolated from a methylomonas sp encoding enzymes in the carbon flux pathway; useful in c1 metabolizing microorganisms for the manipulation of the carbon flux pathway |
| 07/27/2004 | US6767730 Enzymatic polypeptide for use in the treatment of cardiovascular asthma and dietitic disorders |
| 07/27/2004 | US6767727 For treatment of genetic disorders; targets for competitive binding assays; drug screening |
| 07/27/2004 | US6767722 Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, Aspartate 101 or Leucine 137 |
| 07/27/2004 | US6767712 Models of prion disease |
| 07/27/2004 | US6767571 Flavoring agent from filamentous fungus |
| 07/27/2004 | US6767543 Inoculating a mycelial inoculum of an isolate of antrodia camphorata; subjecting culture cultivated to first stage of agitation to obtain second culture proliferation with mycelium; agitation to subject isolate to physiological stress |
| 07/27/2004 | US6767533 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 07/27/2004 | CA2279999C The neurotrophic factor nnt-1 |
| 07/27/2004 | CA2069900C Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
| 07/24/2004 | CA2455701A1 The use of cross-protection to identify novel vaccine candidates for infectious agents |
| 07/22/2004 | WO2004061120A2 Nucleic acids encoding ranpirnase variants and methods of making them |
| 07/22/2004 | WO2004061109A1 Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid |
| 07/22/2004 | WO2004061106A1 Novel mammal-origin protein negatively regulating the expression of antigen presentation-associated molecule such as b7-2 molecule or mhc class ii molecule on cell surface and utilization of the same |
| 07/22/2004 | WO2004061102A1 Cell cycle-controlling protein and utilization thereof |
| 07/22/2004 | WO2004061073A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 07/22/2004 | WO2004060909A2 Increasing production of proteins in gram-positive microorganisms |
| 07/22/2004 | WO2004040955A3 Microbiological method for producing ascorbic acid |
| 07/22/2004 | WO2004014418A3 Neisserial vaccine compositions comprising a combination of antigens |
| 07/22/2004 | WO2004014417A3 Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis |
| 07/22/2004 | WO2004010102A3 Impedance based apparatuses and methods for analyzing cells and particles |
| 07/22/2004 | WO2004005529A3 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 07/22/2004 | WO2004005517A3 L-amidase from rhizobium huautlense |
| 07/22/2004 | WO2003097853A3 Method of screening anti-bacterial agents for effectiveness in treating persistent intracellular infections |
| 07/22/2004 | WO2003092587A3 Modulation of bacterial membrane permeability |
| 07/22/2004 | WO2003082184A3 Truncated lysostaphin molecule with enhanced staphylolytic activity |
| 07/22/2004 | WO2003077863A3 Method for overexpression of zwitterionic polysaccharides |
| 07/22/2004 | WO2003052078A3 Insect g protein-coupled receptor genes and uses thereof |
| 07/22/2004 | WO2003022869A3 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 07/22/2004 | WO2002078637A3 Methods for the production of 3-o-deactivated-4'-monophosphoryl lipid a (3d-mla) |
| 07/22/2004 | WO2002074239A3 Compositions and methods for the treatment and clinical remission of psoriasis |
| 07/22/2004 | US20040143859 Novel proteins and methods for producing the proteins |
| 07/22/2004 | US20040143857 Erythropoietin analog-human serum albumin fusion |
| 07/22/2004 | US20040143854 Using inducible vectors to transform cells and propagate organism for use as drug screening tools; phenotyping |
| 07/22/2004 | US20040143102 Ligand polypeptide for identifying modulators for treatment of nervous system disorders, schizophrenia and arthritis |
| 07/22/2004 | US20040143092 Regulation of human dorsal root receptor-like g protein-coupled receptor |
| 07/22/2004 | US20040142990 Concentrating epothilone in culture; complexing; antiproliferative agents |
| 07/22/2004 | US20040142892 expression cassettes comprising a eukaryotic promoter and a first RNA polymerase promoter operably linked to a nucleic acid encoding a secretable RNA polymerase comprising a RNA polymerase and a secretion domain, and internal ribosome entry site |
| 07/22/2004 | US20040142869 Methods of use of recombinant vasoactive protein from salivary gland of the black fly |
| 07/22/2004 | US20040142837 Alkaline protease |
| 07/22/2004 | US20040142478 Expression vector comprising saccharomyces regulatory sequences for controlling heterologous and homologous gene expression; genetic engineering protein translation |
| 07/22/2004 | US20040142477 Expression vector comprising antisense or inhibitory RNA sequences for use in increasing phyotene concentration in plants; tissue engineering |
| 07/22/2004 | US20040142462 Cell propagation apparatus comprising collapsible bag; bioreactors and tissue culture |
| 07/22/2004 | US20040142458 White rot fungi and method for degrading dioxins by using same |
| 07/22/2004 | US20040142457 Yeast cell bodies containing high concentrations of nucleic acid for use in drug design and flavor enhancement of foods; alcoholic beverages |
| 07/22/2004 | US20040142455 Recombinant botulinum toxins having a soluble C-terminal portion of a heavy chain, an N-terminal portion of a heavy chain and a light chain |
| 07/22/2004 | US20040142454 Polynucleotides coding maltate dehydrogenase for use in transformation of microorganism and fermentive generation of lysine for medicines, foods and animal feeds/nutrients |
| 07/22/2004 | US20040142453 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis |
| 07/22/2004 | US20040142452 Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 07/22/2004 | US20040142447 Microbiological method for producing amides |
| 07/22/2004 | US20040142435 Using genetically engineered methylophilus comprising enhanced 6-phosphogluconate dehydratase and/or 2-keto-3-dexoy-6-phosphogluconate aldolase activities to prepare lysine, leucine, isoleucine and valine; bioreactors |
| 07/22/2004 | US20040142432 Preparing single chain antibodies comprised of camelid subunits for treating and preventing inflammation, allergies, cancer, infections, transplant rejection, autoimmune and muscular disorders |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142427 Nucleotide sequences coding lyase for use as tool in identifying treatments which prevent or inhibit tumor cell metastasis, inflammation and autoimmunity |
| 07/22/2004 | US20040142426 Novel proteins and methods for producing the proteins |
| 07/22/2004 | US20040142424 Transforming cells with genetically engineered phytic acid degrading enzyme for use in improving digestability and nutritional quality of animal feeds |
| 07/22/2004 | US20040142423 Novel polypeptides, DNAs encoding the same and use thereof |
| 07/22/2004 | US20040142421 Pacemake ion channel proteins and uses thereof |
| 07/22/2004 | US20040142418 Novel neurotrophic factors |
| 07/22/2004 | US20040142414 Production of heterologous protein in a minimal culture medium |
| 07/22/2004 | US20040142413 Isolated genome of xyllela fastidiosa and uses thereof |
| 07/22/2004 | US20040142412 Method for identifying <I>listeria</I> <I>monocytogenes </I> and culture medium |
| 07/22/2004 | US20040142394 Method for diagnosing a tumor in a patient determining the concentration of PIBF |
| 07/22/2004 | US20040142372 Comprises nucleotide sequences coding cytokine binding protein for use in identifying modulators for treatment of cell proliferative and inflammatory disorders |
| 07/22/2004 | US20040142366 that effect protein phosphorylation; for drug screening/targets for anticancer agents; genetic engineering |